ロード中...
Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs
BACKGROUND: Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid list price...
保存先:
| 出版年: | BMC Public Health |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6647147/ https://ncbi.nlm.nih.gov/pubmed/31331312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-019-7303-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|